Our analysis showed that the expression of ADORA1 and ADORA2B correlated to that of NT5E. This might be in line with a recent report which indicated that the A2B receptor plays a role in promoting the progression of GBM [31]. This evidence concerns the gene ADORA2B and glioblastoma.